Similar articles

• [Treatment of patients with resistant urogenital infection].

  Kul'chavenia EV, Breusov AA. Kul'chavenia EV, et al. Urologiia. 2011 Jan-Feb;(1):17-21. Urologiia. 2011. PMID: 21504073 Russian.
• [Clinical and microbiological efficacy of metronidazole and ornidazole in the treatment of urogenital trichomoniasis in men].

  Khrianin AA, Reshetnikov OV. Khrianin AA, et al. Antibiot Khimioter. 2006;51(1):18-21. Antibiot Khimioter. 2006. PMID: 16734361 Russian.
• 'Non-orally speaking'.

  Wyllie MG. Wyllie MG. BJU Int. 2009 Aug;104(3):413-4. doi: 10.1111/j.1464-410X.2009.08765.x. BJU Int. 2009. PMID: 19614655 No abstract available.
• [Perspectives of use of moxifloxacin for treatment of urogenital infections].

  Sidorenko SV. Sidorenko SV. Antibiot Khimioter. 2002;47(1):36-42. Antibiot Khimioter. 2002. PMID: 12077939 Review. Russian. No abstract available.
• Immunity in urogenital protozoa.

  Malla N, Goyal K, Dhanda RS, Yadav M. Malla N, et al. Parasite Immunol. 2014 Sep;36(9):400-8. doi: 10.1111/pim.12114. Parasite Immunol. 2014. PMID: 25201404 Review.